Cargando…

Temozolomide Treatment Induces HMGB1 to Promote the Formation of Glioma Stem Cells via the TLR2/NEAT1/Wnt Pathway in Glioblastoma

Formation of glioma stem cells (GSCs) is considered as one of the main reasons of temozolomide (TMZ) resistance in glioma patients. Recent studies have shown that tumor microenvironment-derived signals could promote GSCs formation. But the critical molecule and underlying mechanism for GSCs formatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Xiang-Yu, Zang, Jian, Zheng, Min-Hua, Zhang, Yu-Fei, Yue, Kang-Yi, Cao, Xiu-Li, Cao, Yuan, Li, Xin-Xin, Han, Hua, Jiang, Xiao-Fan, Liang, Liang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7891666/ https://www.ncbi.nlm.nih.gov/pubmed/33614649 http://dx.doi.org/10.3389/fcell.2021.620883

Ejemplares similares

Adenovirus infection promotes the formation of glioma stem cells from glioblastoma cells through the TLR9/NEAT1/STAT3 pathway
por: Zang, Jian, et al.
Publicado: (2020)

Autophagy-based unconventional secretion of HMGB1 in glioblastoma promotes chemosensitivity to temozolomide through macrophage M1-like polarization
por: Li, Zhuang, et al.
Publicado: (2022)

VRK1 Depletion Facilitates the Synthetic Lethality of Temozolomide and Olaparib in Glioblastoma Cells
por: Navarro-Carrasco, Elena, et al.
Publicado: (2021)

LncRNA NEAT1 facilitates glioma progression via stabilizing PGK1
por: Liang, Jingshan, et al.
Publicado: (2022)

Mechanism of RIP2 enhancing stemness of glioma cells induces temozolomide resistance
por: Wang, Xiao‐liang, et al.
Publicado: (2022)

A Ferroptosis-Related Gene Prognostic Index to Predict Temozolomide Sensitivity and Immune Checkpoint Inhibitor Response for Glioma
por: Cai, Yonghua, et al.
Publicado: (2022)

MiR‐3116 sensitizes glioma cells to temozolomide by targeting FGFR1 and regulating the FGFR1/PI3K/AKT pathway
por: Kong, Shiqi, et al.
Publicado: (2020)

Cellular Heterogeneity and Cooperativity in Glioma Persister Cells Under Temozolomide Treatment
por: Rabé, Marion, et al.
Publicado: (2022)

Apcin inhibits the growth and invasion of glioblastoma cells and improves glioma sensitivity to temozolomide
por: Ding, Yiming, et al.
Publicado: (2021)

Molecular Behavior of HMGB1 in the Cochlea Following Noise Exposure and in vitro
por: Xiao, Lili, et al.
Publicado: (2021)

Magnesium sulfate ameliorates sepsis-induced diaphragm dysfunction in rats via inhibiting HMGB1/TLR4/NF-κB pathway
por: Jiang, Jihong, et al.
Publicado: (2020)

Contribution of TGF-Beta-Mediated NLRP3-HMGB1 Activation to Tubulointerstitial Fibrosis in Rat With Angiotensin II-Induced Chronic Kidney Disease
por: Zhang, Kaimin, et al.
Publicado: (2020)

Heparanase confers temozolomide resistance by regulation of exosome secretion and circular RNA composition in glioma
por: Si, Jinchao, et al.
Publicado: (2021)

Regulation of temozolomide resistance in glioma cells via the RIP2/NF‐κB/MGMT pathway
por: Hu, Yu‐Hua, et al.
Publicado: (2021)

CDK4/6 inhibition suppresses tumour growth and enhances the effect of temozolomide in glioma cells
por: Cao, Yingxiao, et al.
Publicado: (2020)

Glioblastoma stem cell (GSC)-derived PD-L1-containing exosomes activates AMPK/ULK1 pathway mediated autophagy to increase temozolomide-resistance in glioblastoma
por: Zheng, Yong, et al.
Publicado: (2021)

Targeted Methylation of the LncRNA NEAT1 Suppresses Malignancy of Renal Cell Carcinoma
por: Chen, Jieqing, et al.
Publicado: (2021)

BACH1 Promotes Temozolomide Resistance in Glioblastoma through Antagonizing the Function of p53
por: Nie, Er, et al.
Publicado: (2016)

Metabolic Syndrome and Autophagy: Focus on HMGB1 Protein
por: Frisardi, Vincenza, et al.
Publicado: (2021)

UBE2T Promotes Temozolomide Resistance of Glioblastoma Through Regulating the Wnt/β-Catenin Signaling Pathway
por: Wang, Yang, et al.
Publicado: (2023)

Role of HMGB1/TLR4 and IL-1β/IL-1R1 Signaling Pathways in Epilepsy
por: Zhang, Shaohui, et al.
Publicado: (2022)

Combined Delivery of Temozolomide and siPLK1 Using Targeted Nanoparticles to Enhance Temozolomide Sensitivity in Glioma
por: Shi, Hui, et al.
Publicado: (2020)

Hypoxanthine phosphoribosyl transferase 1 metabolizes temozolomide to activate AMPK for driving chemoresistance of glioblastomas
por: Yin, Jianxing, et al.
Publicado: (2023)

Recent advances of NEAT1-miRNA interactions in cancer: The interactions of NEAT1 with miRNAs
por: Zhou, Hui, et al.
Publicado: (2022)

rhHMGB1 drives osteoblast migration in a TLR2/TLR4- and NF-κB-dependent manner
por: Li, Ming-Jing, et al.
Publicado: (2016)

MCCK1 enhances the anticancer effect of temozolomide in attenuating the invasion, migration and epithelial‐mesenchymal transition of glioblastoma cells in vitro and in vivo
por: Liu, Tie, et al.
Publicado: (2019)

The SIRT1-HMGB1 axis: Therapeutic potential to ameliorate inflammatory responses and tumor occurrence
por: Wei, Lanyi, et al.
Publicado: (2022)

Radiotherapy-induced cell death activates paracrine HMGB1-TLR2 signaling and accelerates pancreatic carcinoma metastasis
por: Chen, Xuelian, et al.
Publicado: (2018)

Aloin promotes cell apoptosis by targeting HMGB1-TLR4-ERK axis in human melanoma cells
por: Li, Pan, et al.
Publicado: (2020)

Temozolomide in malignant glioma
por: Dresemann, Gregor
Publicado: (2010)

HMGB1 is a mediator of cuproptosis-related sterile inflammation
por: Liu, Jiao, et al.
Publicado: (2022)

YAP promotes autophagy and progression of gliomas via upregulating HMGB1
por: Zhao, Min, et al.
Publicado: (2021)

Berberine reduces temozolomide resistance by inducing autophagy via the ERK1/2 signaling pathway in glioblastoma
por: Qu, Huiling, et al.
Publicado: (2020)

Activation of the HMGB1-TLR4-NF-κB pathway may occur in patients with atopic eczema
por: Wang, Yong, et al.
Publicado: (2017)

Glycyrrhizin mitigates radiation‐induced acute lung injury by inhibiting the HMGB1/TLR4 signalling pathway
por: Zheng, Lei, et al.
Publicado: (2019)

LNX1 Modulates Notch1 Signaling to Promote Expansion of the Glioma Stem Cell Population during Temozolomide Therapy in Glioblastoma
por: Baisiwala, Shivani, et al.
Publicado: (2020)

Neuronal markers are expressed in human gliomas and NSE knockdown sensitizes glioblastoma cells to radiotherapy and temozolomide
por: Yan, Tao, et al.
Publicado: (2011)

Aberrant Expression of ADARB1 Facilitates Temozolomide Chemoresistance and Immune Infiltration in Glioblastoma
por: Lu, Can, et al.
Publicado: (2022)

Effect of long-term adjuvant temozolomide chemotherapy on primary glioblastoma patient survival
por: Huang, Bin, et al.
Publicado: (2021)

HOXD‐AS2‐STAT3 feedback loop attenuates sensitivity to temozolomide in glioblastoma
por: Zhang, Zuo‐Xin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_m6tuh2269m3qntlk6q5ckgv4uh